학술논문
A phase Ib study to evaluate the oral selective estrogen receptor degrader GDC-9545 alone or combined with palbociclib in metastatic ER-positive HER2-negative breast cancer.
Document Type
Journal
Author
Lim, Elgene; Jhaveri, Komal L.; Perez-Fidalgo, Jose Alejandro; Bellet, Meritxell; Boni, Valentina; Garcia, Jose Manuel Perez; Estevez, Laura; Bardia, Aditya; Turner, Nicholas C.; Villanueva, Rafael; Cobo, Sara Lopez-Tarruella; Im, Seock-Ah; Kim, Sung-Bae; Gates, Mary R.; Monemi, Sharareh; Chen, Ya-Chi; Moore, Heather; Loi, Sherene; Sohn, Joohyuk
Source
Subject
Language
English
ISSN
15277755